The relapsing-remitting type of MS (RRMS) is mainly treated with immunomodulating drugs like interferon-beta (IFN-β) and glatiramer acetate (GA)[1,2]. This evidence concerns the gene IFNB1 and relapsing-remitting multiple sclerosis.